Vaginal DHEA for Women After Breast Cancer

NCT01724242 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Inability to recruit patients

Conditions

Vaginal Dryness
Breast Cancer
Urinary Incontinence
Quality of Life
Sexual Satisfaction

Interventions

DRUG: Vaginal DHEA
DRUG: Placebo

Sponsor

Hadassah Medical Organization